Clinical Trials Logo

Clinical Trial Summary

Throughout the Military Health System, pregnant mothers are issued a spiral-bound guide that provides week by week information about pregnancy, preventive health messages, appointment information, and space to record their experiences throughout their pregnancy. When used accordingly, the evidence-based guide is an effective tool for motivating patients to participate in their own healthcare and achieve care goals. However, the spiral-bound paper modality results in patients forgetting the book for appointments or losing it. By testing a mobile application (app) from the current publication, the MHS leverages the efforts which created the guide while increasing patient and provider use.

The multisite testing (randomized controlled trial) of a mobile application developed from the current spiral-bound "Pregnancy and Childbirth: A Goal Oriented Guide to Prenatal Care" created by the VA and DoD provides an innovative, cost-effective opportunity to improve provider-patient communication and patient care.


Clinical Trial Description

The study was conducted in the women's health and family medicine departments of one community hospital and two medical centers across three states (Georgia, Nevada, and Virginia). In this hospital system, women are distributed a spiral notebook at their obstetric care intake appointment, which generally is scheduled for 8-10 weeks gestation. The spiral notebook is designed for two purposes: 1) patient education of what happens throughout pregnancy, and 2) patient record keeping of the patient's own pregnancy experience, including space for recording weight, blood pressure, and journaling about what they experience between prenatal appointments. The mobile app used in this study was designed for the same two purposes and contained identical content, though through a mobile design interface (available on both Android and iOS platforms). After the pilot study, patient feedback on the mobile app was used to create a beta version. Notable differences were a feature for users to change font size, a search function, and weekly reminders. No substantive content changed. This randomized controlled study had one intervention (mobile application) and one control (standard of care - spiral notebook) group. The study was approved by the first author's Institutional Review Board.

At each medical center, the obstetrics intake nurse serially screened new obstetrics patients for inclusion criteria from May to November 2015. If patients met inclusion criteria, the nurse invited the patient to talk to a research assistant about the study. Exclusion criteria included conditions that would elevate the patient's care to complicated obstetrics care (e.g., cardiovascular disease, diabetes mellitus, renal disorder, etc.). This was intended to capture a low-risk obstetrics patient population that would follow a standard 4-week pathway of care, in which patients attend a prenatal appointment once every four weeks during pregnancy.

The study used pre-assigned block randomization (each block n = 40) to balance the conditions throughout recruitment. Following consent and baseline measures, participants were randomized to the two conditions. Providers were blinded to patient participation in the study.

Surveys were completed at four prenatal appointments, 10-12 weeks, 28 weeks, 32 weeks, and 36 weeks gestation. All data collection was conducted with paper-and-pencil surveys in the clinic, immediately before and following each clinical appointment. At each appointment, patient weight and blood pressure were also recorded from the patient's electronic medical record.

At baseline, self-reported measures included demographics, health literacy, and patient activation. Health literacy was assessed using the self-reported Functional, Communicative, Critical Health Literacy Scale (Ishikawa, Takeuchi, & Yano, 2008) Patient activation was assessed with the validated, licensed patient activation measure (PAM) (Greene & Hibbard, 2012; Greene, Hibbard, Sacks, & Overton, 2013; Hibbard, Mahoney, Stockard, & Tusler, 2005; Hibbard et al., 2004), which uses 13 Likert-type items to create a continuous patient activation measure on a scale of 0 (not activated) to 100 (most activated). PAM was also replicated at time 4 (32 week appointment). As a surrogate measure, patient activation was also assessed at a behavioral level by asking patients at 36 weeks how many mobile apps they had used throughout their pregnancy.

Use was assessed with three measures. Before each appointment, patients completed two items regarding use of the education and engagement tool. First they indicated if they had brought the mobile app/notebook to the appointment with them (yes/no). Then, they reported how frequently they had used the tool over the past month 1) to look for information and 2) to record information (never = 0, once = 1, weekly = 4, or daily = 28).

Following each appointment, patients completed five subscales of the validated Prenatal Interpersonal Processes of Care (PIPC) scale (Wong et al., 2004), including elicitation/responsiveness to the patient, explanations of care, empowerment, patient-centered decision making, and emotional support. Responses to each item were transformed onto a 0 (negative perception) to 100 (positive perception) scale, and items are averaged to create subscales. Then subscales are averaged to calculate the overall PIPC scale.

At delivery, outcomes were recorded from the health record: gestational age, birth weight, and mode of delivery (vaginal or Caesarean section). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03305003
Study type Interventional
Source Henry M. Jackson Foundation for the Advancement of Military Medicine
Contact
Status Completed
Phase N/A
Start date May 1, 2015
Completion date December 31, 2015

See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Completed NCT02408315 - Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE) Phase 3